REG-BARCLAYS PLC FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
01/10/2020 07:20
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201001:nBw6K0Tz4a
FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
FORM 8.3
Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 28 September 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,288,462 1.78% 463,830 0.36%
(2) Derivatives (other than options):
355,000 0.28% 388,524 0.30%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4) TOTAL:
2,643,462 2.05% 852,354 0.66%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 7 205.9050 USD
Purchase 8 206.1300 USD
Purchase 16 206.9475 USD
Purchase 58 205.6800 USD
Purchase 85 204.8500 USD
Purchase 96 201.1800 USD
Purchase 100 202.7600 USD
Purchase 100 207.4000 USD
Purchase 100 207.8400 USD
Purchase 100 206.3900 USD
Purchase 100 206.1600 USD
Purchase 100 205.9000 USD
Purchase 102 205.9388 USD
Purchase 110 202.9186 USD
Purchase 202 206.4839 USD
Purchase 300 201.7733 USD
Purchase 300 205.4333 USD
Purchase 346 202.8802 USD
Purchase 363 207.1257 USD
Purchase 367 206.1268 USD
Purchase 377 203.6636 USD
Purchase 386 205.0134 USD
Purchase 393 206.8652 USD
Purchase 397 207.0132 USD
Purchase 400 203.6975 USD
Purchase 422 206.0816 USD
Purchase 483 204.2953 USD
Purchase 486 205.5467 USD
Purchase 588 206.8417 USD
Purchase 588 206.4829 USD
Purchase 686 205.2494 USD
Purchase 837 207.5215 USD
Purchase 956 206.6062 USD
Purchase 956 207.3602 USD
Purchase 1,057 205.6401 USD
Purchase 1,184 207.4494 USD
Purchase 1,258 207.6501 USD
Purchase 1,564 206.1802 USD
Purchase 2,137 207.2824 USD
Purchase 3,683 206.8576 USD
Purchase 4,609 205.6621 USD
Purchase 5,969 207.2997 USD
Purchase 6,359 206.7307 USD
Purchase 11,326 207.0633 USD
Purchase 15,455 205.7840 USD
Purchase 20,393 206.8500 USD
Sale 1 207.2100 USD
Sale 38 206.8600 USD
Sale 100 206.8200 USD
Sale 100 205.5000 USD
Sale 100 206.7550 USD
Sale 161 207.3368 USD
Sale 169 206.5194 USD
Sale 200 204.3900 USD
Sale 200 205.5225 USD
Sale 341 204.4753 USD
Sale 548 204.2086 USD
Sale 569 205.0194 USD
Sale 587 206.8411 USD
Sale 957 205.5237 USD
Sale 1,073 205.9366 USD
Sale 1,260 206.0037 USD
Sale 1,507 206.4172 USD
Sale 3,630 206.8496 USD
Sale 5,987 206.8500 USD
Sale 6,795 207.0949 USD
Sale 7,992 205.7480 USD
Sale 10,939 205.5643 USD
Sale 15,272 206.8143 USD
Sale 25,647 207.1477 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 1 Oct 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200930006047/en/
(https://www.businesswire.com/news/home/20200930006047/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC - Transaction in Own Shares
AnnouncementREG - Barclays PLC Greencore Group PLC - Form 8.3 GREENCORE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement